Palasis Maria — SEC Form 4 filings
SEC reporting owner CIK 1810701. 15 Form 4 filings on record with FilingPulse; latest filed 2026-05-26.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-20 to 2026-05-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 4 filings — 6,079 shares, $99,056 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 1,287 shares @ $26.86 ($34,567) in Beta Bionics, Inc., filed 2025-11-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | Director | 6 | — | 4 legs · 2,812 sh · $79,386 | 4 |
| Lyra Therapeutics, Inc. (LYRA) | Principal Executive Officer, Director | 9 | — | 2 legs · 3,267 sh · $19,670 | 6 |
Form 4 filings — Palasis Maria
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-26 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 16,965 @ $0 | EDGAR |
| 2026-04-03 | 4 | Lyra Therapeutics, Inc. (LYRA) | Disposition to issuer (D): 2,000 @ $0 | EDGAR |
| 2026-01-14 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 3,997 @ $0 | EDGAR |
| 2026-01-08 | 4 | Lyra Therapeutics, Inc. (LYRA) | Sale (S): 1,702 @ $3.36 | EDGAR |
| 2025-12-02 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 906 @ $29.33 · Sale (S): 500 @ $29.96 | EDGAR |
| 2025-11-05 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 1,287 @ $26.86 · Sale (S): 119 @ $27.45 | EDGAR |
| 2025-10-08 | 4/A | Lyra Therapeutics, Inc. (LYRA) | Holdings only — no transactions reported | EDGAR |
| 2025-10-03 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 3,667 (derivative) @ $0 | EDGAR |
| 2025-07-14 | 4 | Lyra Therapeutics, Inc. (LYRA) | Sale (S): 1,565 @ $8.91 | EDGAR |
| 2025-03-18 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 11,247 @ $0 | EDGAR |
| 2025-02-03 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 9,137 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 800,000 @ $0 | EDGAR |
| 2024-12-11 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 183,333 (derivative) @ $0 | EDGAR |
| 2024-10-18 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2024-03-20 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1810701 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →